Influenza and respiratory syncytial virus during the COVID-19 pandemic: Time for a new paradigm?
Por:
Binns E, Koenraads M, Hristeva L, Flamant A, Baier-Grabner S, Loi M, Lempainen J, Osterheld E, Ramly B, Chakakala-Chaziya J, Enaganthi N, Simó-Nebot S and Buonsenso D
Publicada:
1 ene 2022
Ahead of Print:
1 oct 2021
Resumen:
Seasonal epidemics of influenza and the respiratory syncytial virus (RSV) are the cause of substantial morbidity and mortality among children. During the global coronavirus disease 2019 (COVID-19) pandemic, the epidemiology of these viruses seems to have changed dramatically. In Australia and New Zealand, a significant decrease in both influenza and bronchiolitis have been noticed during usual peak seasons. Data from early months of winter seasons in Europe are showing similar trends. This current scenario imposes a reconsideration of the paradigm that toddlers and young schoolchildren are the main drivers of seasonal RSV outbreaks and respiratory epidemics in general. In this article, we summarize current literature, address current knowledge or role of adults in the RSV epidemiology, describe the lessons learned from pertussis epidemics and call the international community to better understand the community transmission dynamics of respiratory infections in all age groups. This can allow the establishment of better and more affordable preventive measures in the whole population level, which can ultimately save millions of child lives.
Filiaciones:
Binns E:
Department of Paediatrics, Christchurch Hospital, Christchurch, New Zealand
Koenraads M:
Alder Hey Children's Hospital, Liverpool, UK
Hristeva L:
General Paediatrics/Neonates, London, UK
Flamant A:
Cliniques Universitaires Saint-Luc, Brussels, Belgium
Baier-Grabner S:
Department of Paediatrics and Adolescent Medicine, Klinik Ottakring, Vienna Healthcare Group, Vienna, Austria
Loi M:
Children's Intensive Care Unit, KK Women's and Children's Hospital, Singapore, Singapore
Lempainen J:
Department of Paediatrics, Institute of Biomedicine and Clinical Microbiology, University of Turku and Turku University Hospital, Turku, Finland
Osterheld E:
Department of Paediatrics, Centre Hospitalier de Mayotte, Mayotte, France
Ramly B:
Paediatric Department, Children Health Ireland, Dublin, Ireland
Paediatric Department, Hospital Raja Permaisuri Bainun, Ipoh, Malaysia
Chakakala-Chaziya J:
Paediatric Department, Muzu Central Hospital, Ministry of Health, Muzu, Malawi
Enaganthi N:
Paediatric Department, Sri Ramachandra Medical College & RI, Chennai, Tamil Nadu, India
Simó-Nebot S:
Infectious Diseases and Systemic Inflammatory Response in Paediatrics, Infectious Diseases Unit, Sant Joan de Déu Hospital Research Foundation, Barcelona, Spain
Buonsenso D:
Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Global Health Research Institute, Istituto di Igiene, Università Cattolica del Sacro Cuore, Rome, Italy
Green Submitted, Bronze
|